WSJ News Exclusive | Biden’s Pick for U.S. Health-Research Chief Stalled by Drug-Costs Fight
Sen. Bernie Sanders won’t hold a hearing on the nomination of NIH director until the White House lays out a plan to curb high drug costs.
Sen. Bernie Sanders won’t hold a hearing on the nomination of NIH director until the White House lays out a plan to curb high drug costs.
By turning evidence into practice in real time, the CardioHealth Alliance aims to enable our health care systems to move away from a model of…
November 11, 2023 – By randomizing 10,000 adult patients, ARTEMIS will evaluate the effects of a study medicine versus placebo on cardiovascular outcomes in patients…
By turning evidence into practice in real time, the CardioHealth Alliance aims to enable our health care systems to move away from a model of…
Dr. Monica M. Bertagnolli won bipartisan approval despite opposition from Senator Bernie Sanders, the chairman of the Senate health committee.
The North Carolina city’s evolution from a faded tobacco town to a diverse cultural and culinary destination has been years in the making.
Integrating Clinical Studies Into Health Care Delivery: Post-Market Evidence Generation for Medical ProductsVirtual Public Meeting
The tremendous potential of stem cells to treat a wide range of diseases has captured the imaginations of patients, practitioners, scientists and entrepreneurs worldwide for…
ESPN’s College GameDay travels to Durham for No. 18 Duke vs. No. 9 Notre Dame.
Monica Bertagnolli, Biden’s nominee to run the National Institutes of Health, will get a confirmation hearing in the Senate next month.
Companies developing weight-loss drugs have raised or made deals valued at more than $1.4 billion since about a year ago.